A new COVID-19 subvariant, NB.1.8.1, is making headlines as it spreads rapidly across multiple countries. In this episode, we break down what scientists and public health officials currently know about NB.1.8.1: its mutations, symptoms, transmissibility, vaccine effectiveness, and how it compares to other Omicron subvariants like XBB and KP.2. COVID-19 Educational Videos: https://youtube.com/playlist?list=PLf5bMa9_tvRjDwCpaD06b6fMOt1FEBki1&si=Awicjyq66xzs1wfg 📰👇SIGN UP FOR OUR FREE WEEKLY NEWSLETTER👍👍 https://whiteboardmedicine.kit.com/634ccbe783 👍Become a WhiteBoard Medicine member for early access and perks! https://www.youtube.com/channel/UCiMhM7xCTT8b5SJRnhpH7Ag/join 👇DON'T MISS OUT - JOIN OUR PATREON COMMUNITY TODAY 👇 https://www.patreon.com/WhiteBoardMedicine We appreciate the support! DISCLAIMER THIS EPISODE DOES NOT PROVIDE MEDICAL ADVICE. The information, including but not limited to, text, graphics, images, audio and other material contained on this podcast are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read, watched, or listened to on this video, or any other videos, reports, texts tweets or other sources.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related